Market Outlook
The Global Immunoprotein Diagnostic Testing Market, valued at USD 10.11 billion in 2024, is projected to reach USD 15.77 billion by 2030, growing at a steady CAGR of 7.65%. This growth is driven by advancements in diagnostic technologies, such as chemiluminescence and enzyme-based immunoassays, which have increased the speed and accuracy of disease detection.
The rising prevalence of chronic diseases, including autoimmune disorders, cancer, and infectious diseases, has significantly